Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

A man developed skin issues from cancer medication, which improved with specific treatments.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

Erlotinib can cause hair loss as a side effect.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Erlotinib can cause hair loss and texture changes.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.